Clinical and molecular biomarkers predicting response to PARP inhibitors in ovarian cancer

Objective: To determine the useful biomarker for predicting the effects of poly-(ADP ribose)-polymerase (PARP) inhibitors in Japanese patients with ovarian cancer. Methods: We collected clinical information and performed molecular biological analysis on 42 patients with ovarian, fallopian tube, and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of gynecologic oncology 2024-07, Vol.35 (4), p.1
Hauptverfasser:	Takahiro Nozaki, Ikuko Sakamoto, Keiko Kagami, Kenji Amemiya, Yosuke Hirotsu, Hitoshi Mochizuki, Masao Omata
Format:	Artikel
Sprache:	kor
Schlagworte:	Genomics Homologous Recombination Mutation Ovarian Cancer
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!